How will Japan align its drug laws with international standards?

Question

Accepted Answer

Japan to Revise Drug Laws for Medicinal Marijuana in Line with International Standards

A Japanese health ministry panel has recommended revising the nation’s drug laws to permit the importation and use of medicinal marijuana products. This move is intended to address unmet medical needs and to bring Japan's regulations into greater alignment with international standards. The proposed changes will specifically cover marijuana products that have undergone established safety and efficacy assessments, adhering to the stringent requirements already in place for pharmaceuticals and medical devices.
Harmonisation with Global Pharmaceutical Regulations

The recommendation to revise Japan's drug laws is fundamentally driven by a desire to harmonise its regulatory framework with those of other nations regarding medicinal cannabis. This alignment aims to ensure that patients in Japan can access treatments that are already approved and utilised in other parts of the world, provided they meet rigorous safety and efficacy criteria. Such an approach is common in the pharmaceutical industry, where international consistency facilitates the availability of innovative medicines.
Addressing Unmet Medical Needs and Specific Treatments

A key impetus for this legal revision is to facilitate the use of specific cannabis-derived medications, such as Epidiolex, an epilepsy drug currently undergoing clinical trials in Japan. By allowing the importation and use of such products, Japan can begin to address medical needs for which existing treatments may be insufficient. This is particularly relevant given the low historical prevalence of marijuana use in Japan, with only 1.4% of the population having ever used it, contrasting sharply with figures of 20-40% in Western countries.
Ensuring Safety and Efficacy Through Existing Frameworks

The proposed revision stipulates that only marijuana products with confirmed safety and efficacy, assessed under Japan's existing laws governing pharmaceuticals and medical devices, will be eligible for importation and use. This means that any medicinal marijuana product would need to undergo a thorough evaluation process to demonstrate its therapeutic benefits and the absence of unacceptable risks. This approach leverages Japan's established regulatory pathways for approving medicines, ensuring a cautious and evidence-based introduction of these new treatments.

Reading history

Hide →

This history is cleared when the page is closed.

How will Japan align its drug laws with international standards?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends